キャンバスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/04/07 | 1,435 | 1,516 | 1,425 | 1,479 | +23 | +1.6% | 895,900 |
2023/04/06 | 1,476 | 1,533 | 1,447 | 1,456 | -39 | -2.6% | 715,800 |
2023/04/05 | 1,545 | 1,595 | 1,492 | 1,495 | -64 | -4.1% | 1,375,900 |
2023/04/04 | 1,442 | 1,569 | 1,440 | 1,559 | +95 | +6.5% | 2,350,500 |
2023/04/03 | 1,452 | 1,548 | 1,420 | 1,464 | -40 | -2.7% | 1,682,400 |
2023/03/31 | 1,357 | 1,630 | 1,354 | 1,504 | +141 | +10.3% | 3,754,400 |
2023/03/30 | 1,306 | 1,390 | 1,305 | 1,363 | +49 | +3.7% | 730,200 |
2023/03/29 | 1,344 | 1,361 | 1,312 | 1,314 | -36 | -2.7% | 564,000 |
2023/03/28 | 1,396 | 1,407 | 1,344 | 1,350 | -28 | -2% | 609,800 |
2023/03/27 | 1,426 | 1,434 | 1,359 | 1,378 | -74 | -5.1% | 764,500 |
2023/03/24 | 1,450 | 1,460 | 1,419 | 1,452 | +14 | +1% | 470,900 |
2023/03/23 | 1,470 | 1,480 | 1,422 | 1,438 | -58 | -3.9% | 622,400 |
2023/03/22 | 1,524 | 1,541 | 1,488 | 1,496 | -14 | -0.9% | 495,000 |
2023/03/20 | 1,568 | 1,578 | 1,501 | 1,510 | -30 | -1.9% | 446,700 |
2023/03/17 | 1,520 | 1,555 | 1,483 | 1,540 | +41 | +2.7% | 653,500 |
2023/03/16 | 1,471 | 1,510 | 1,445 | 1,499 | -20 | -1.3% | 673,200 |
2023/03/15 | 1,500 | 1,563 | 1,474 | 1,519 | +63 | +4.3% | 1,336,700 |
2023/03/14 | 1,542 | 1,558 | 1,450 | 1,456 | -110 | -7% | 1,313,200 |
2023/03/13 | 1,559 | 1,588 | 1,544 | 1,566 | -33 | -2.1% | 552,900 |
2023/03/10 | 1,603 | 1,635 | 1,576 | 1,599 | -3 | -0.2% | 854,200 |
2023/03/09 | 1,610 | 1,635 | 1,560 | 1,602 | -19 | -1.2% | 1,347,700 |
2023/03/08 | 1,620 | 1,663 | 1,595 | 1,621 | -5 | -0.3% | 1,428,900 |
2023/03/07 | 1,630 | 1,778 | 1,611 | 1,626 | +9 | +0.6% | 4,191,300 |
2023/03/06 | 1,710 | 1,724 | 1,614 | 1,617 | -83 | -4.9% | 2,989,500 |
2023/03/03 | 1,585 | 1,745 | 1,526 | 1,700 | +129 | +8.2% | 5,161,800 |
2023/03/02 | 1,563 | 1,663 | 1,506 | 1,571 | +43 | +2.8% | 3,657,800 |
2023/03/01 | 1,675 | 1,682 | 1,518 | 1,528 | -163 | -9.6% | 4,012,700 |
2023/02/28 | 1,761 | 1,810 | 1,604 | 1,691 | -82 | -4.6% | 3,847,900 |
2023/02/27 | 2,160 | 2,233 | 1,728 | 1,773 | -427 | -19.4% | 5,211,700 |
2023/02/24 | 2,199 | 2,228 | 2,118 | 2,200 | +25 | +1.1% | 1,784,100 |
2023/02/22 | 2,199 | 2,263 | 2,105 | 2,175 | -4 | -0.2% | 1,763,700 |
2023/02/21 | 2,165 | 2,346 | 2,112 | 2,179 | -1 | ±0% | 4,295,000 |
2023/02/20 | 2,101 | 2,375 | 2,088 | 2,180 | -121 | -5.3% | 5,753,300 |
2023/02/17 | 2,951 | 2,975 | 2,301 | 2,301 | -500 | -17.9% | 10,154,600 |
2023/02/16 | 2,315 | 2,801 | 2,308 | 2,801 | +500 | +21.7% | 5,476,200 |
2023/02/15 | 2,336 | 2,366 | 2,225 | 2,301 | +2 | +0.1% | 3,790,600 |
2023/02/14 | 2,110 | 2,308 | 2,110 | 2,299 | +176 | +8.3% | 5,711,500 |
2023/02/13 | 1,964 | 2,276 | 1,961 | 2,123 | +123 | +6.2% | 7,014,000 |
2023/02/10 | 1,875 | 2,005 | 1,815 | 2,000 | +63 | +3.3% | 3,265,400 |
2023/02/09 | 1,998 | 2,028 | 1,894 | 1,937 | -79 | -3.9% | 3,893,800 |
2023/02/08 | 1,925 | 2,068 | 1,890 | 2,016 | +108 | +5.7% | 7,920,000 |
2023/02/07 | 1,712 | 1,984 | 1,703 | 1,908 | +174 | +10% | 8,827,600 |
2023/02/06 | 1,680 | 1,792 | 1,660 | 1,734 | +37 | +2.2% | 2,128,400 |
2023/02/03 | 1,833 | 1,837 | 1,681 | 1,697 | -42 | -2.4% | 2,744,900 |
2023/02/02 | 1,750 | 1,819 | 1,654 | 1,739 | -47 | -2.6% | 4,046,800 |
2023/02/01 | 1,756 | 1,933 | 1,752 | 1,786 | -8 | -0.4% | 11,867,900 |
2023/01/31 | 1,543 | 1,878 | 1,512 | 1,794 | +262 | +17.1% | 17,460,400 |
2023/01/30 | 1,382 | 1,532 | 1,373 | 1,532 | +300 | +24.4% | 6,844,600 |
2023/01/27 | 1,245 | 1,255 | 1,222 | 1,232 | -19 | -1.5% | 555,700 |
2023/01/26 | 1,266 | 1,283 | 1,226 | 1,251 | -1 | -0.1% | 839,900 |
401~
450
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「CANBAS」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
CANBAS | 88,700円 | - | - | 0.00% | - | 7.36倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
Chordia | 24,900円 | - | - | 0.00% | - | 4.09倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
ステラファーマ | 49,400円 | +245.7% | - | 0.00% | - | 5.46倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
メディシノバ | 31,200円 | - | - | - | - | - |
|
- |
市場注目の銘柄
チャート関連のコラム